- This event has passed.
ALS Drug Development Webinar Series Part 3: Ethical Considerations
May 5, 2021 @ 1:00 pm - 2:00 pm EDT
Join us for the third installment of the NEALS webinar series on ALS drug development moderated by Dr. Richard Bedlack from the Duke ALS Clinic. This series will include talks on the preclinical development of potential therapies, the regulatory pathway, the science of trials, ethical considerations, the clinical trial site level overview, and the importance of patient engagement.
Wed, May 5, 2021 10:00 AM – 11:00 AM PDT
In this webinar, Dr. Simmons will discuss the ethical issues surrounding informed consent, placebo controls, placebo-to-drug ratio, “fairness” of inclusion/exclusion criteria and patient selection, remote vs. in-person visits, open-label extensions, expanded access and “Right to Try” pathways.
